| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/07/2003 | CA2473984A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
| 08/07/2003 | CA2473810A1 Fgfr agonists |
| 08/07/2003 | CA2473249A1 New corticosteroids |
| 08/07/2003 | CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 08/07/2003 | CA2473158A1 Treatment of rheumatoid arthritis using imatinib |
| 08/07/2003 | CA2473128A1 Genetic polymorphisms in the preprotachykinin gene |
| 08/07/2003 | CA2443023A1 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 08/06/2003 | EP1332761A1 Agonists of fibroblast growth factor receptors (FGFR) |
| 08/06/2003 | EP1332372A2 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 08/06/2003 | EP1332206A1 Recombinant alpha-l-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 08/06/2003 | EP1332151A1 Pyranoside derivatives |
| 08/06/2003 | EP1332149A1 Glycerophosphoinositol derivatives as modulators of cytosolic a2 phospholipase |
| 08/06/2003 | EP1332147A1 Thieno[2,3-c isoquinolines for use as inhibitors of parp |
| 08/06/2003 | EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/06/2003 | EP1332144A1 Indole derivatives as pde5-inhibitors |
| 08/06/2003 | EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/06/2003 | EP1332132A2 Enamine derivatives as cell adhesion molecules |
| 08/06/2003 | EP1332131A2 Acid derivatives useful as serine protease inhibitors |
| 08/06/2003 | EP1332128A1 Benzamidine derivatives comprising a sulfate group serving as ltb4 antagonists |
| 08/06/2003 | EP1331943A2 Nucleic acid molecules and polypeptides for immune modulation |
| 08/06/2003 | EP1331940A1 Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 08/06/2003 | EP1331937A2 Dibenzoxazepine alpha v integrin receptor antagonist |
| 08/06/2003 | EP1331932A2 Therapeutic uses for ip 3? receptor-mediated calcium channel modulators |
| 08/06/2003 | EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors |
| 08/06/2003 | EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
| 08/06/2003 | EP0983064B1 PYRROLES AS sPLA2 INHIBITORS |
| 08/06/2003 | EP0804465B1 Novel elastase inhibitors |
| 08/06/2003 | EP0701449B1 Process for the preparation of an oral solid dosage form containing diclofenac |
| 08/06/2003 | CN1434830A 2-aminocarbonyl-9H-punine derivatives |
| 08/06/2003 | CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives |
| 08/06/2003 | CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/06/2003 | CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434818A Novel compounds |
| 08/06/2003 | CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors |
| 08/06/2003 | CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases |
| 08/06/2003 | CN1434810A Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials |
| 08/06/2003 | CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists |
| 08/06/2003 | CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors |
| 08/06/2003 | CN1434799A Cyclic amp-specific phosphodiesterase inhibitors |
| 08/06/2003 | CN1434798A Pyrrolidines which inhibit CAMP-specific PDE |
| 08/06/2003 | CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons |
| 08/06/2003 | CN1434794A Adamantane derivatives |
| 08/06/2003 | CN1434727A Anglogenesis and vascular permeability modulators and inhibitors |
| 08/06/2003 | CN1434715A Pharmaceutical compositions |
| 08/06/2003 | CN1434713A Sustained-release formulation of a cyclooxygenase-2 inhibitor |
| 08/06/2003 | CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use |
| 08/06/2003 | CN1434707A Method and compositions for preventing hormone induced adverse effects |
| 08/06/2003 | CN1434705A Use of hydroxide-releasing agents as skin permeation enhancers |
| 08/06/2003 | CN1434704A System and method for extended delivery of therapeutic agent with its receptor loading dose |
| 08/06/2003 | CN1433806A Medicated liquor for treating chronic osteonosus |
| 08/06/2003 | CN1433794A Medicinal pillow for preventing and curing cervical vertebra pain |
| 08/06/2003 | CN1433767A Active extracted composition of teasel root and notoginseng and use in medicine |
| 08/06/2003 | CN1117089C Substituted 2(2,6-dioxopiperidin-3-yl)phthaliomides and -1-xoisoindolines and method of reducing TNF-alpha levels |
| 08/06/2003 | CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 08/06/2003 | CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors |
| 08/06/2003 | CN1116897C Parathyroid hormone medicine coposition |
| 08/06/2003 | CN1116896C Powder medicine and preparation process thereof |
| 08/06/2003 | CN1116892C Bagged blood circulation-activating and obstruction-dredgnig granule and its preparation |
| 08/06/2003 | CN1116889C Chinese medicine preparation for rheumatic and rheumatoid diseases |
| 08/06/2003 | CN1116882C Chinese medicine composition for curing spur and hyperosteoeny and its preparing method |
| 08/06/2003 | CN1116880C Use of puffer liver oil in preparing food for curing poisonous drug dependence |
| 08/05/2003 | US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 08/05/2003 | US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 08/05/2003 | US6602914 Treatment of a disease that is mediated by the expression or suppression of a redox sensitive gene, for example MCP-1, IL-6 and thrombin receptor; antiinflammatory agents; cardio-vascular disorders; atherosclerosis; immunology |
| 08/05/2003 | US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease |
| 08/05/2003 | US6602885 Viricides, organ transplants, antiarthritic agents |
| 08/05/2003 | US6602878 Acylquanidine derivatives, method for preparing same, application as medicines and pharmaceutical compositions containing them |
| 08/05/2003 | US6602877 Imidazolyl-cyclic acetals |
| 08/05/2003 | US6602876 Adhesion receptor antagonists |
| 08/05/2003 | US6602872 Substituted pyridazines having cytokine inhibitory activity |
| 08/05/2003 | US6602868 Administering a heterocyclic amine or a phenylazacycloalkane |
| 08/05/2003 | CA2275595C Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists |
| 07/31/2003 | WO2003062821A1 Modulators of the clc-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states |
| 07/31/2003 | WO2003062469A2 Gene matn3 or matrilin-3 linked to osteoarthritis treatment |
| 07/31/2003 | WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 07/31/2003 | WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR |
| 07/31/2003 | WO2003062276A2 Multimers of receptor-binding ligands |
| 07/31/2003 | WO2003062275A1 Glycoisoforms of adiponectin and uses thereof |
| 07/31/2003 | WO2003062252A1 Edg receptor agonists |
| 07/31/2003 | WO2003062245A1 Fused bicyclic pyrimidine derivatives |
| 07/31/2003 | WO2003062241A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 07/31/2003 | WO2003062236A1 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 07/31/2003 | WO2003062227A1 Rho-kinase inhibitors |
| 07/31/2003 | WO2003062225A1 Pyrimidine derivatives as rho-kinase inhibitors |
| 07/31/2003 | WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| 07/31/2003 | WO2003062191A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | WO2003062189A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters |
| 07/31/2003 | WO2003061690A1 Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 07/31/2003 | WO2003061667A1 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/31/2003 | WO2003061666A1 Phospholipid bodies and use thereof in the treatment of inflammatory and autoimmune diseases |
| 07/31/2003 | WO2003061665A1 Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen |
| 07/31/2003 | WO2003061659A1 Treating stress response with chemokine receptor ccr5 modulators |
| 07/31/2003 | WO2003061652A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 07/31/2003 | WO2003061634A1 Sustained release pharmaceutical composition |
| 07/31/2003 | WO2003061620A2 Peptide-carrying bodies for immune response |
| 07/31/2003 | WO2003061565A2 Use of calmodulin to promote bone regeneration |
| 07/31/2003 | WO2003041649A3 Cyanoalkylamino derivatives as protease inhibitors |
| 07/31/2003 | WO2003018545B1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3? |